Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takafumi Nakamachi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Circulation Research|March 25, 2006
Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cellsDaisuke Ogawa, Takashi Nomiyama, Takafumi Nakamachi, et al.
The Journal of Biological Chemistry|September 2, 2006
The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferationTakashi Nomiyama, Takafumi Nakamachi, Florence Gizard, et al.
Metabolism: Clinical and Experimental|July 14, 2009
Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitusNoriyuki Ozeki, Kenji Hara, Chikako Yatsuka, et al.
Diabetes Research and Clinical Practice|June 24, 2009
Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetesYoshimasa Aso, Kenji Hara, Noriyuki Ozeki, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 22, 2009
Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunctionYoshimasa Aso, Ruriko Suganuma, Sadao Wakabayashi, et al.
Diabetes|March 16, 2007
PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetesTakafumi Nakamachi, Takashi Nomiyama, Florence Gizard, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Circulation Research|March 25, 2006
Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cellsDaisuke Ogawa, Takashi Nomiyama, Takafumi Nakamachi, et al.
The Journal of Biological Chemistry|September 2, 2006
The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferationTakashi Nomiyama, Takafumi Nakamachi, Florence Gizard, et al.
Metabolism: Clinical and Experimental|July 14, 2009
Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitusNoriyuki Ozeki, Kenji Hara, Chikako Yatsuka, et al.
Diabetes Research and Clinical Practice|June 24, 2009
Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetesYoshimasa Aso, Kenji Hara, Noriyuki Ozeki, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 22, 2009
Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunctionYoshimasa Aso, Ruriko Suganuma, Sadao Wakabayashi, et al.
Diabetes|March 16, 2007
PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetesTakafumi Nakamachi, Takashi Nomiyama, Florence Gizard, et al.
Pageof 1